SS

Stephen Squinto

Morgan Life Sciences Private Capital at J.P. Morgan Asset Management

New York, New York

Overview

Work Experience

JM

J.P. Morgan Asset Management

  • Chief Investment Officer, JP Morgan Life Sciences Private Capital

    2022 - Current

GB

Gennao Bio

  • Executive Chairman

    2021 - 2022

O

OrbiMed

  • Executive Partner

    2019 - 2022

  • Venture Partner

    2015 - 2019

OrbiMed Advisors

  • Executive Partner

    2019 - 2022

AP

Alexion Pharmaceuticals, Inc.

  • Co-Founder; Exec VP, Head of R&D

    1992 - 2015

RP

Regeneron Pharmaceuticals, Inc.

  • Senior Leadership, Early Company Builder

    1988 - 1992

Education

Investments

Enlaza Therapeutics

Series A

Total Funding: $160M

iECURE

Series A

Total Funding: $120M

Gennao Bio

Series A

Total Funding: $40M

Chemomab

Post Ipo Equity

Total Funding: $76M

Relevant Websites